Coverage of oncology drug indication concepts and compositional semantics by SNOMED-CT.

Steven H. Brown, Brent A Bauer, Dietland L. Wahner-Roedler, Peter L. Elkin

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVE: To evaluate SNOMED-CT 's ability to represent simple and compositional concepts in FDA approved oncology drug indications. METHODS: Oncology drug indications were decomposed into single and compositional concepts. SNOMED-CT's coverage of single concepts and the semantics needed to create compositional concepts were evaluated using automated and manual techniques. RESULTS: SNOMED-CT covered 86.3% of single concepts present in oncology drug indications; 11.3% of indications were covered completely. Coverage was best for concepts describing diseases, anatomy, and patient characteristics. Medications accounted for 50.5% of missing concepts. Excluding drug names, 45.2% of indications were completely represented. SNOMED-CT's semantics completely represented 60.1% of compositional expressions. CONCLUSIONS: SNOMED-CT's overall coverage of the concepts in oncology drug indications was good. Improvements or alternatives are needed for medications and semantics.

Original languageEnglish (US)
Pages (from-to)115-119
Number of pages5
JournalAMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium
StatePublished - 2003
Externally publishedYes

Fingerprint

Systematized Nomenclature of Medicine
Semantics
Pharmaceutical Preparations
Names
Anatomy

Cite this

Coverage of oncology drug indication concepts and compositional semantics by SNOMED-CT. / Brown, Steven H.; Bauer, Brent A; Wahner-Roedler, Dietland L.; Elkin, Peter L.

In: AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium, 2003, p. 115-119.

Research output: Contribution to journalArticle

@article{1282a3369c40406cac4053de9fc68717,
title = "Coverage of oncology drug indication concepts and compositional semantics by SNOMED-CT.",
abstract = "OBJECTIVE: To evaluate SNOMED-CT 's ability to represent simple and compositional concepts in FDA approved oncology drug indications. METHODS: Oncology drug indications were decomposed into single and compositional concepts. SNOMED-CT's coverage of single concepts and the semantics needed to create compositional concepts were evaluated using automated and manual techniques. RESULTS: SNOMED-CT covered 86.3{\%} of single concepts present in oncology drug indications; 11.3{\%} of indications were covered completely. Coverage was best for concepts describing diseases, anatomy, and patient characteristics. Medications accounted for 50.5{\%} of missing concepts. Excluding drug names, 45.2{\%} of indications were completely represented. SNOMED-CT's semantics completely represented 60.1{\%} of compositional expressions. CONCLUSIONS: SNOMED-CT's overall coverage of the concepts in oncology drug indications was good. Improvements or alternatives are needed for medications and semantics.",
author = "Brown, {Steven H.} and Bauer, {Brent A} and Wahner-Roedler, {Dietland L.} and Elkin, {Peter L.}",
year = "2003",
language = "English (US)",
pages = "115--119",
journal = "AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium",
issn = "1559-4076",
publisher = "American Medical Informatics Association",

}

TY - JOUR

T1 - Coverage of oncology drug indication concepts and compositional semantics by SNOMED-CT.

AU - Brown, Steven H.

AU - Bauer, Brent A

AU - Wahner-Roedler, Dietland L.

AU - Elkin, Peter L.

PY - 2003

Y1 - 2003

N2 - OBJECTIVE: To evaluate SNOMED-CT 's ability to represent simple and compositional concepts in FDA approved oncology drug indications. METHODS: Oncology drug indications were decomposed into single and compositional concepts. SNOMED-CT's coverage of single concepts and the semantics needed to create compositional concepts were evaluated using automated and manual techniques. RESULTS: SNOMED-CT covered 86.3% of single concepts present in oncology drug indications; 11.3% of indications were covered completely. Coverage was best for concepts describing diseases, anatomy, and patient characteristics. Medications accounted for 50.5% of missing concepts. Excluding drug names, 45.2% of indications were completely represented. SNOMED-CT's semantics completely represented 60.1% of compositional expressions. CONCLUSIONS: SNOMED-CT's overall coverage of the concepts in oncology drug indications was good. Improvements or alternatives are needed for medications and semantics.

AB - OBJECTIVE: To evaluate SNOMED-CT 's ability to represent simple and compositional concepts in FDA approved oncology drug indications. METHODS: Oncology drug indications were decomposed into single and compositional concepts. SNOMED-CT's coverage of single concepts and the semantics needed to create compositional concepts were evaluated using automated and manual techniques. RESULTS: SNOMED-CT covered 86.3% of single concepts present in oncology drug indications; 11.3% of indications were covered completely. Coverage was best for concepts describing diseases, anatomy, and patient characteristics. Medications accounted for 50.5% of missing concepts. Excluding drug names, 45.2% of indications were completely represented. SNOMED-CT's semantics completely represented 60.1% of compositional expressions. CONCLUSIONS: SNOMED-CT's overall coverage of the concepts in oncology drug indications was good. Improvements or alternatives are needed for medications and semantics.

UR - http://www.scopus.com/inward/record.url?scp=4344708784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344708784&partnerID=8YFLogxK

M3 - Article

C2 - 14728145

AN - SCOPUS:4344708784

SP - 115

EP - 119

JO - AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium

JF - AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium

SN - 1559-4076

ER -